<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7125728/results/search/test_trace/results.xml">
  <result pre="antibodies can therefore be thought of as probes for the" exact="detection" post="of viral infections, suggesting that they might be used"/>
  <result pre="use of a radiolabeled hepatitis C protease inhibitor to image" exact="infection" post="in animals or humans and provide a quantitative measure"/>
  <result pre="PET have been used to detect host responses to viral" exact="infection" post="and examine how PET has been employed to track"/>
  <result pre="a component of a number of compounds employed for the" exact="treatment" post="of syphilis. To determine their distribution within the body,"/>
  <result pre="pico- to nanomolar range. 3 Imaging host responses to viral" exact="infection" post="Radionuclide imaging has been used to study viral diseases"/>
  <result pre="infection, they cannot identify its causative agent, so a microbiologic" exact="diagnosis" post="must be obtained by collecting appropriate samples and performing"/>
  <result pre="when acyclovir was approved as an antiviral drug for the" exact="treatment" post="of HSV infections. The ability of this and other"/>
  <result pre="the central nervous system, the increased permeability associated with viral" exact="infection" post="permitted the entry of a sufficient amount of probe"/>
  <result pre="Kuruppu et al., 2007). It has recently been shown that" exact="treatment" post="of herpesvirus-induced cancers, such as Burkitt's lymphoma, with the"/>
  <result pre="researchers were able to use 125I-FIAU to visualize sites of" exact="infection" post="by SPECT (Davis et al., 2009). Fig. 9 PET/CT"/>
  <result pre="to eradicate HIV in individuals with low levels of residual" exact="infection" post="(Casadevall et al., 2007). A similar strategy, using antibodies"/>
  <result pre="et al., 2009). Others are now under evaluation for the" exact="treatment" post="of hepatitis C. •The C-terminal portion of the flavivirus"/>
  <result pre="or rimantadine could be used to localize an influenza virus" exact="infection" post="and track it's spread, both in laboratory animals and"/>
  <result pre="the target of the human mab palivizumab, used to prevent" exact="infection" post="in high-risk infants (Georgescu and Chemaly, 2009). A new"/>
  <result pre="and Nipah, are the targets of peptide mimics, which block" exact="infection" post="in vitro at low nanomolar concentrations (Porotto et al.,"/>
  <result pre="A number of such compounds are now licensed for the" exact="treatment" post="of HIV infection (Sluis-Cremer and Tachedjian, 2008). Because no"/>
  <result pre="such compounds are now licensed for the treatment of HIV" exact="infection" post="(Sluis-Cremer and Tachedjian, 2008). Because no equivalent of the"/>
  <result pre="inhibitors as effective antiviral drugs was first proven for the" exact="treatment" post="of HIV infection, and a number of different compounds"/>
  <result pre="an effective probe (Lefebvre and Schiffer, 2008). 9 Getting started:" exact="testing" post="a drug or antibody for its potential as an"/>
  <result pre="that it may also be preferentially retained at sites of" exact="infection" post="in vivo. Additional studies would include testing the specificity"/>
  <result pre="at sites of infection in vivo. Additional studies would include" exact="testing" post="the specificity of binding, by adding a large excess"/>
  <result pre="labeled probe, to see if competition takes place. If initial" exact="testing" post="of the 14C- or 3H-labeled drug confirms its potential"/>
  <result pre="References References AlauddinM.M.ContiP.S.MazzaS.M.HamzehF.M.LeverJ.R.9-[(3-[18F]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG): a potential imaging agent of viral" exact="infection" post="and gene therapy using PETNucl. Med. Biol.2319967877928940722 BeigelJ.BrayM.Current and"/>
  <result pre="[F]FEAU PETPLoS One42009e478919274083 BrunettiA.BergG.Di ChiroG.CohenR.M.YarchoanR.PizzoP.A.BroderS.EddyJ.FulhamM.J.FinnR.D.Reversal of brain metabolic abnormalities following" exact="treatment" post="of AIDS dementia complex with 3′-azido-2′,3′-dideoxythymidine (AZT, zidovudine): a"/>
  <result pre="nodal activationAIDS20200698599316603850 BuscombeJ.R.OyenW.J.GrantA.ClaessensR.A.van der MeerJ.CorstensF.H.EllP.J.MillerR.F.Indium-111-labeled polyclonal human immunoglobulin: identifying focal" exact="infection" post="in patients positive for human immunodeficiency virusJ. Nucl. Med.341993162116258410271"/>
  <result pre="virusJ. Nucl. Med.341993162116258410271 BuursmaA.R.de VriesE.F.GarssenJ.KeglerD.van WaardeA.SchirmJ.HospersG.A.MulderN.H.VaalburgW.KleinH.C.[18F]FHPG positron emission tomography for" exact="detection" post="of herpes simplex virus (HSV) in experimental HSV encephalitisJ."/>
  <result pre="cent inhibition (I50) of an enzymatic reactionBiochem. Pharmacol.221973309931084202581 CleatorG.M.KlapperP.E.LewisA.G.SharmaH.L.LongsonM.Specific neuro-radiological" exact="diagnosis" post="of herpes encephalitis in an animal modelArch. Virol.10119881123415476 DadachovaE.PatelM.C.ToussiS.ApostolidisC.MorgensternA.BrechbielM.W.GornyM.K.Zolla-PaznerS.CasadevallA.GoldsteinH.Targeted"/>
  <result pre="in living animals using PETJ. Nucl. Med.4520041560157015347725 HamedI.A.WenzlJ.E.LeonardJ.C.AltshulerG.P.PedersonJ.A.Pulmonary cytomegalovirus infection:" exact="detection" post="by Gallium 67 imaging in the transplant patientArch. Intern."/>
  <result pre="64-0802Bioorg. Med. Chem. Lett.1820081260126318226899 KumarR.BasuS.TorigianD.AnandV.ZhuangH.AlaviA.Role of modern imaging techniques for" exact="diagnosis" post="of infection in the era of 18F-fluorodeoxyglucose positron emission"/>
  <result pre="Chem. Lett.1820081260126318226899 KumarR.BasuS.TorigianD.AnandV.ZhuangH.AlaviA.Role of modern imaging techniques for diagnosis of" exact="infection" post="in the era of 18F-fluorodeoxyglucose positron emission tomographyClin. Microbiol."/>
  <result pre="KumarV.Radiolabeled white blood cells and direct targeting of micro-organisms for" exact="infection" post="imagingQ. J. Nucl. Med. Mol. Imaging49200532533816407816 KuruppuD.BrownellA.L.ZhuA.YuM.WangX.KuluY.FuchsB.C.KawasakiH.TanabeK.K.Positron emission tomography"/>
  <result pre="the therapy of syphilisBr. J. Vener. Dis.11925505721772477 LoveC.TomasM.B.TroncoG.G.PalestroC.J.FDG PET of" exact="infection" post="and inflammationRadiographics2520051357136816160116 MackieG.C.F-18 fluorodeoxyglucose positron emission tomographic imaging of"/>
  <result pre="PriceR.W.SaitoY.FoxJ.J.Prospects for the use of radiolabeled antiviral drugs in the" exact="diagnosis" post="of herpes simplex encephalitisBiochem. Pharmacol.321983245524616311219 PrichardM.N.Function of human cytomegalovirus"/>
  <result pre="encephalitisBiochem. Pharmacol.321983245524616311219 PrichardM.N.Function of human cytomegalovirus UL97 kinase in viral" exact="infection" post="and its inhibition by maribavirRev. Med. Virol.19200921522919434630 PrichardM.N.KeithK.A.JohnsonM.P.HardenE.A.McBrayerA.LuoM.QiuS.ChattopadhyayD.FanX.TorrenceP.F.KernE.R.Selective phosphorylation"/>
  <result pre="an ultra-potent antibody for the prevention of respiratory syncytial virus" exact="infection" post="in the upper and lower respiratory tractJ. Mol. Biol.368200765266517362988"/>
 </snippets>
</snippetsTree>
